Submit Deal

ACORN BIOVENTURES

Summary

Acorn Bioventures is a private and small-capitalization biotech, specialty pharma and medical device companies.

Deals Overview

Total Deals6

Valued Deals5

Total Value£ 409 M

Avg. Deal Size£ 82 M

Market Context

Senior Management

Anders Hove
Founder & Partner

Sort

16 Mar 2020|United Kingdom|Biotechnology

Target: FREELINE THERAPEUTICS

Bidder: WELLINGTON MANAGEMENT

8 Service Providers

2 Target | 6 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 91 M

Value

17 May 2021|United States|Pharmaceuticals

Target: AADI BIOSCIENCE INC

Bidder: AERPIO PHARMACEUTICALS INC

22 Service Providers

4 Target | 18 Bidder

44 Dealmakers

23 Target | 21 Bidder

n/a

Value

15 Nov 2022|United States|Health Care Services

Target: CG ONCOLOGY

Bidder: ALLY BRIDGE GROUP

11 Service Providers

3 Target | 8 Bidder

12 Dealmakers

4 Target | 8 Bidder

£ 101 M

Value

06 Mar 2023|United States|Biotechnology

Target: BICARA THERAPEUTICS

Bidder: PREMJI INVEST

15 Service Providers

3 Target | 12 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 89 M

Value

23 May 2023|United States|Pharmaceuticals

Target: ONKURE THERAPEUTICS

Bidder: SURVEYOR CAPITAL

11 Service Providers

1 Target | 10 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 43 M

Value

02 Aug 2023|United States|Health Care Services

Target: CG ONCOLOGY

Bidder: AVIDITY PARTNERS

5 Service Providers

3 Target | 2 Bidder

7 Dealmakers

5 Target | 2 Bidder

£ 82 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy